Header Logo

Connection

SANKAR NAVANEETHAN to Humans

Back to Details
This is a "connection" page, showing publications SANKAR NAVANEETHAN has written about Humans.
SANKAR NAVANEETHAN
Connection Strength
1.788
Humans
  1. Therapeutic approaches for pulmonary hypertension in patients with chronic kidney disease. Curr Opin Nephrol Hypertens. 2024 Sep 01; 33(5):494-502.
    View in: PubMed
    Score: 0.018
  2. Kidney Function Trajectories and Right Heart Failure Following LVAD Implantation. J Am Heart Assoc. 2024 Mar 05; 13(5):e031305.
    View in: PubMed
    Score: 0.018
  3. Emerging evidence for glucagon-like peptide-1 agonists in slowing chronic kidney disease progression. Curr Opin Nephrol Hypertens. 2024 05 01; 33(3):331-336.
    View in: PubMed
    Score: 0.018
  4. Understanding Prescribing Practices and Patient Experiences with Renin Angiotensin System Inhibitors Use in Chronic Kidney Disease: A Qualitative Study. Cardiorenal Med. 2024; 14(1):34-44.
    View in: PubMed
    Score: 0.018
  5. Does Serum Creatinine Reflect Muscle Mass in Patients with Kidney Failure? J Am Soc Nephrol. 2024 01 01; 35(1):1-2.
    View in: PubMed
    Score: 0.018
  6. Emerging strategies to reduce kidney function decline and improve cardiovascular outcomes. Curr Opin Nephrol Hypertens. 2023 09 01; 32(5):401-403.
    View in: PubMed
    Score: 0.017
  7. Racial and Ethnic Disparities and Facility-Level Variation in GLP-1 RA Prescription among US Veterans with CKD. Clin J Am Soc Nephrol. 2023 11 01; 18(11):1479-1482.
    View in: PubMed
    Score: 0.017
  8. Steroidal or non-steroidal MRAs: should we still enable RAASi use through K binders? Nephrol Dial Transplant. 2023 05 31; 38(6):1355-1365.
    View in: PubMed
    Score: 0.017
  9. Documented Adverse Drug Reactions and Discontinuation of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers in Chronic Kidney Disease. Am J Nephrol. 2023; 54(3-4):126-135.
    View in: PubMed
    Score: 0.017
  10. Echocardiographic parameters and cardiovascular disease in Japanese- and US-based CKD cohorts. Kidney Int. 2023 05; 103(5):837-839.
    View in: PubMed
    Score: 0.017
  11. Predictors, Disparities, and Facility-Level Variation: SGLT2 Inhibitor Prescription Among US Veterans With CKD. Am J Kidney Dis. 2023 07; 82(1):53-62.e1.
    View in: PubMed
    Score: 0.017
  12. Diabetes Management in Chronic Kidney Disease: Synopsis of the KDIGO 2022 Clinical Practice Guideline Update. Ann Intern Med. 2023 03; 176(3):381-387.
    View in: PubMed
    Score: 0.017
  13. Distinctive kidney function trajectories following left ventricular assist device implantation. J Heart Lung Transplant. 2022 12; 41(12):1798-1807.
    View in: PubMed
    Score: 0.016
  14. Editorial: Advancements in the management of kidney disease and electrolyte derangements. Curr Opin Nephrol Hypertens. 2022 09 01; 31(5):395-398.
    View in: PubMed
    Score: 0.016
  15. Progress in the management of patients with diabetes and chronic kidney disease. Curr Opin Nephrol Hypertens. 2022 09 01; 31(5):456-463.
    View in: PubMed
    Score: 0.016
  16. Updated US Prevalence Estimates for Chronic Kidney Disease Stage and Complications Using the New Race-Free Equation to Estimate Glomerular Filtration Rate. JAMA Netw Open. 2022 02 01; 5(2):e220460.
    View in: PubMed
    Score: 0.016
  17. Nephrology Considerations in the Management of Durable and Temporary Mechanical Circulatory Support. Kidney360. 2022 03 31; 3(3):569-579.
    View in: PubMed
    Score: 0.016
  18. Effects of the 2021 CKD-EPI Creatinine eGFR Equation among a National US Veteran Cohort. Clin J Am Soc Nephrol. 2022 02; 17(2):283-285.
    View in: PubMed
    Score: 0.015
  19. Considerations in the Study of Body Mass Index Variability. J Am Soc Nephrol. 2021 10; 32(10):2395-2397.
    View in: PubMed
    Score: 0.015
  20. Renin-angiotensin system blocker discontinuation and adverse outcomes in chronic kidney disease. Nephrol Dial Transplant. 2021 09 27; 36(10):1893-1899.
    View in: PubMed
    Score: 0.015
  21. Treatment options for managing obesity in chronic kidney disease. Curr Opin Nephrol Hypertens. 2021 09 01; 30(5):516-523.
    View in: PubMed
    Score: 0.015
  22. Are All SGLT2 Inhibitors Created Equal? Clin J Am Soc Nephrol. 2021 09; 16(9):1309-1311.
    View in: PubMed
    Score: 0.015
  23. Incidence and predictors of non-alcoholic fatty liver disease among patients with chronic kidney disease. Nephrol Dial Transplant. 2021 07 23; 36(8):1546-1548.
    View in: PubMed
    Score: 0.015
  24. Management of type 2 diabetes in chronic kidney disease. BMJ Open Diabetes Res Care. 2021 07; 9(1).
    View in: PubMed
    Score: 0.015
  25. Black Race Coefficient in GFR Estimation and Prevalence of CKD-Related Complications. Clin J Am Soc Nephrol. 2021 10; 16(10):1562-1564.
    View in: PubMed
    Score: 0.015
  26. Mortality, Kidney Failure, and Hospitalization Among Medicare Beneficiaries With CKD and Pulmonary Hypertension. Am J Kidney Dis. 2021 11; 78(5):700-708.e1.
    View in: PubMed
    Score: 0.015
  27. Black Race Coefficient in GFR Estimation and Diabetes Medications in CKD: National Estimates. J Am Soc Nephrol. 2021 06 01; 32(6):1319-1321.
    View in: PubMed
    Score: 0.015
  28. Long-term inter-platform reproducibility, bias, and linearity of commercial PDFF MRI methods for fat quantification: a multi-center, multi-vendor phantom study. Eur Radiol. 2021 Oct; 31(10):7566-7574.
    View in: PubMed
    Score: 0.015
  29. Early eGFR decline after SGLT2i initiation: knowns and unknowns. Kidney Int. 2021 03; 99(3):548-550.
    View in: PubMed
    Score: 0.015
  30. Prevalence, correlates and outcomes of absolute and functional iron deficiency anemia in nondialysis-dependent chronic kidney disease. Nephrol Dial Transplant. 2021 01 01; 36(1):129-136.
    View in: PubMed
    Score: 0.015
  31. Diabetes Management in Chronic Kidney Disease: Synopsis of the 2020 KDIGO Clinical Practice Guideline. Ann Intern Med. 2021 03; 174(3):385-394.
    View in: PubMed
    Score: 0.014
  32. Adiposity, Physical Function, and Their Associations With Insulin Resistance, Inflammation, and Adipokines in CKD. Am J Kidney Dis. 2021 01; 77(1):44-55.
    View in: PubMed
    Score: 0.014
  33. [Hospitalization and Critical Illness in Chronic Kidney Disease]. Cardiorenal Med. 2020; 10(5):302-312.
    View in: PubMed
    Score: 0.014
  34. Diagnosis and Management of Pulmonary Hypertension in Patients With CKD. Am J Kidney Dis. 2020 06; 75(6):935-945.
    View in: PubMed
    Score: 0.014
  35. Association between intensity of statin therapy and mortality in persons with chronic kidney disease. Nephrol Dial Transplant. 2020 02 01; 35(2):312-319.
    View in: PubMed
    Score: 0.014
  36. Classification of Pulmonary Hypertension in CKD. Am J Kidney Dis. 2020 05; 75(5):690-692.
    View in: PubMed
    Score: 0.014
  37. Readmissions after Acute Kidney Injury during Left Ventricular Assist Device Implantation Hospitalization. Am J Nephrol. 2020; 51(3):172-181.
    View in: PubMed
    Score: 0.014
  38. Bariatric Surgery for ESKD Patients: Why, When, and How? Clin J Am Soc Nephrol. 2019 Aug 07; 14(8):1125-1127.
    View in: PubMed
    Score: 0.013
  39. Primary and Secondary Prevention of Cardiovascular Disease in Patients with Chronic Kidney Disease. Curr Atheroscler Rep. 2019 06 22; 21(9):32.
    View in: PubMed
    Score: 0.013
  40. Effects of Treatment of Metabolic Acidosis in CKD: A Systematic Review and Meta-Analysis. Clin J Am Soc Nephrol. 2019 07 05; 14(7):1011-1020.
    View in: PubMed
    Score: 0.013
  41. Acute Kidney Injury With Ventricular Assist Device Placement: National Estimates of Trends and Outcomes. Am J Kidney Dis. 2019 11; 74(5):650-658.
    View in: PubMed
    Score: 0.013
  42. Characteristics and Outcomes of Patients With Aortic Stenosis and Chronic Kidney Disease. J Am Heart Assoc. 2019 02 05; 8(3):e009980.
    View in: PubMed
    Score: 0.013
  43. Trials and Tribulations in Studying Kidney Outcomes With Intentional Weight Loss. Circulation. 2019 01 15; 139(3):376-379.
    View in: PubMed
    Score: 0.013
  44. What are the Risk Factors for One-Year Mortality in Older Patients with Chronic Kidney Disease? An Analysis of the Cleveland Clinic CKD Registry. Nephron. 2019; 141(2):98-104.
    View in: PubMed
    Score: 0.013
  45. Estimated GFR Decline and Tubular Injury Biomarkers With Intensive Blood Pressure Control. Am J Kidney Dis. 2019 01; 73(1):4-7.
    View in: PubMed
    Score: 0.013
  46. Cause-Specific Mortality in Patients with Chronic Kidney Disease and Atrial Fibrillation. Am J Nephrol. 2018; 48(1):36-45.
    View in: PubMed
    Score: 0.012
  47. Implantable Ventricular Assist Device Use and Outcomes in People With End-Stage Renal Disease. J Am Heart Assoc. 2018 07 06; 7(14).
    View in: PubMed
    Score: 0.012
  48. Trends in Left Ventricular Assist Device Implantation and Associated Mortality Among Patients With and Without ESRD. Am J Kidney Dis. 2018 10; 72(4):620-622.
    View in: PubMed
    Score: 0.012
  49. High-density lipoprotein cholesterol and causes of death in chronic kidney disease. J Clin Lipidol. 2018 Jul - Aug; 12(4):1061-1071.e7.
    View in: PubMed
    Score: 0.012
  50. Blood pressure parameters and morbid and mortal outcomes in nondialysis-dependent chronic kidney disease. Curr Opin Nephrol Hypertens. 2018 01; 27(1):16-22.
    View in: PubMed
    Score: 0.012
  51. Blood Pressure Parameters and their Associations with Death in Patients with Chronic Kidney Disease. Curr Hypertens Rep. 2017 Oct 18; 19(11):92.
    View in: PubMed
    Score: 0.012
  52. Pragmatic Randomized, Controlled Trial of Patient Navigators and Enhanced Personal Health Records in CKD. Clin J Am Soc Nephrol. 2017 Sep 07; 12(9):1418-1427.
    View in: PubMed
    Score: 0.011
  53. Blood pressure parameters are associated with all-cause and cause-specific mortality in chronic kidney disease. Kidney Int. 2017 11; 92(5):1272-1281.
    View in: PubMed
    Score: 0.011
  54. Omega-3 Fatty Acids (Fish Oil) Supplementation and Albuminuria: Not a Slam Dunk. J Am Heart Assoc. 2017 07 14; 6(7).
    View in: PubMed
    Score: 0.011
  55. Associations of dysnatremias with mortality in chronic kidney disease. Nephrol Dial Transplant. 2017 Jul 01; 32(7):1204-1210.
    View in: PubMed
    Score: 0.011
  56. Diabetes Control and the Risks of ESRD and Mortality in?Patients?With CKD. Am J Kidney Dis. 2017 Aug; 70(2):191-198.
    View in: PubMed
    Score: 0.011
  57. Inflammation as a Therapeutic Target To Improve Vascular Function in Kidney Disease. J Am Soc Nephrol. 2017 03; 28(3):723-725.
    View in: PubMed
    Score: 0.011
  58. Phosphate Binders: The Evidence Gap Persists. Am J Kidney Dis. 2016 11; 68(5):667-670.
    View in: PubMed
    Score: 0.011
  59. Bariatric surgery for obesity-associated decline in?kidney function: filling the?knowledge gap? Kidney Int. 2016 07; 90(1):28-30.
    View in: PubMed
    Score: 0.011
  60. Copeptin and Decline in Kidney Function. Am J Nephrol. 2016; 44(1):19-21.
    View in: PubMed
    Score: 0.011
  61. Obstructive and Restrictive Lung Function Measures and CKD: National Health and Nutrition Examination Survey (NHANES) 2007-2012. Am J Kidney Dis. 2016 09; 68(3):414-21.
    View in: PubMed
    Score: 0.010
  62. Mortality Outcomes of Patients with Chronic Kidney Disease and Chronic Obstructive Pulmonary Disease. Am J Nephrol. 2016; 43(1):39-46.
    View in: PubMed
    Score: 0.010
  63. Body mass index and causes of death in chronic kidney disease. Kidney Int. 2016 Mar; 89(3):675-82.
    View in: PubMed
    Score: 0.010
  64. A Trial of Lifestyle Modification on Cardiopulmonary, Inflammatory, and Metabolic Effects among Obese with Chronic Kidney Disease. Am J Nephrol. 2015; 42(4):274-81.
    View in: PubMed
    Score: 0.010
  65. Prevalence, Predictors, and Outcomes of Pulmonary Hypertension in CKD. J Am Soc Nephrol. 2016 Mar; 27(3):877-86.
    View in: PubMed
    Score: 0.010
  66. Predicting Mortality after Severe Acute Kidney Injury: A Step Forward but Not Close to the Finish Line. Am J Nephrol. 2015; 42(1):54-6.
    View in: PubMed
    Score: 0.010
  67. BP Targets in Older Adults with CKD: Additional Evidence, but Uncertainty Continues. Clin J Am Soc Nephrol. 2015 Sep 04; 10(9):1501-3.
    View in: PubMed
    Score: 0.010
  68. Serum Potassium, End-Stage Renal Disease and Mortality in Chronic Kidney Disease. Am J Nephrol. 2015; 41(6):456-63.
    View in: PubMed
    Score: 0.010
  69. Outcomes of transient ischemic attack in maintenance dialysis patients and those with chronic kidney disease. Nephrol Dial Transplant. 2016 Jan; 31(1):128-32.
    View in: PubMed
    Score: 0.010
  70. Elevated pulmonary pressure: A novel risk marker in kidney disease? Kidney Int. 2015 Jul; 88(1):7-9.
    View in: PubMed
    Score: 0.010
  71. Implantable cardioverter-defibrillators in patients with CKD: a propensity-matched mortality analysis. Clin J Am Soc Nephrol. 2015 Jul 07; 10(7):1119-27.
    View in: PubMed
    Score: 0.010
  72. Renal resistive index and mortality in chronic kidney disease. Hypertension. 2015 Aug; 66(2):382-8.
    View in: PubMed
    Score: 0.010
  73. Cause-Specific Deaths in Non-Dialysis-Dependent CKD. J Am Soc Nephrol. 2015 Oct; 26(10):2512-20.
    View in: PubMed
    Score: 0.010
  74. Patients as stakeholders in setting kidney disease research priorities. Am J Kidney Dis. 2015 May; 65(5):641-3.
    View in: PubMed
    Score: 0.010
  75. Patency and Complications of Translumbar Dialysis Catheters. Semin Dial. 2015 Jul-Aug; 28(4):E41-7.
    View in: PubMed
    Score: 0.010
  76. Bariatric surgery, kidney function, insulin resistance, and adipokines in patients with decreased GFR: a cohort study. Am J Kidney Dis. 2015 Feb; 65(2):345-7.
    View in: PubMed
    Score: 0.009
  77. Outcomes of infected cardiovascular implantable devices in dialysis patients. Am J Nephrol. 2014; 40(3):280-7.
    View in: PubMed
    Score: 0.009
  78. Adiposity measures, lean body mass, physical activity and mortality: NHANES 1999-2004. BMC Nephrol. 2014 Jul 08; 15:108.
    View in: PubMed
    Score: 0.009
  79. Practice patterns of phosphate binder use and their associations with mortality in chronic kidney disease. Clin Nephrol. 2014 Jul; 82(1):16-25.
    View in: PubMed
    Score: 0.009
  80. Presence and outcomes of kidney disease in patients with pulmonary hypertension. Clin J Am Soc Nephrol. 2014 May; 9(5):855-63.
    View in: PubMed
    Score: 0.009
  81. Albuminuria: when urine predicts kidney and cardiovascular disease. Cleve Clin J Med. 2014 Jan; 81(1):41-50.
    View in: PubMed
    Score: 0.009
  82. Nontraumatic subarachnoid hemorrhage in maintenance dialysis hospitalizations: trends and outcomes. Stroke. 2014 Jan; 45(1):71-6.
    View in: PubMed
    Score: 0.009
  83. Aldosterone breakthrough during angiotensin receptor blocker use: more questions than answers? Clin J Am Soc Nephrol. 2013 Oct; 8(10):1637-9.
    View in: PubMed
    Score: 0.009
  84. Prognostic importance of serum alkaline phosphatase in CKD stages 3-4 in a clinical population. Am J Kidney Dis. 2013 Oct; 62(4):703-10.
    View in: PubMed
    Score: 0.009
  85. Outcomes of patients receiving maintenance dialysis admitted over weekends. Am J Kidney Dis. 2013 Oct; 62(4):763-70.
    View in: PubMed
    Score: 0.009
  86. Cardiac resynchronization therapy in CKD: a systematic review. Clin J Am Soc Nephrol. 2013 Aug; 8(8):1293-303.
    View in: PubMed
    Score: 0.009
  87. Electronic health records: a new tool to combat chronic kidney disease? Clin Nephrol. 2013 Mar; 79(3):175-83.
    View in: PubMed
    Score: 0.008
  88. Metabolic syndrome, ESRD, and death in CKD. Clin J Am Soc Nephrol. 2013 Jun; 8(6):945-52.
    View in: PubMed
    Score: 0.008
  89. Obesity, anthropometric measures and chronic kidney disease complications. Am J Nephrol. 2012; 36(3):219-27.
    View in: PubMed
    Score: 0.008
  90. Serum triglycerides and risk for death in Stage 3 and Stage 4 chronic kidney disease. Nephrol Dial Transplant. 2012 Aug; 27(8):3228-34.
    View in: PubMed
    Score: 0.008
  91. Overweight, obesity and intentional weight loss in chronic kidney disease: NHANES 1999-2006. Int J Obes (Lond). 2012 Dec; 36(12):1585-90.
    View in: PubMed
    Score: 0.008
  92. Serum bicarbonate and mortality in stage 3 and stage 4 chronic kidney disease. Clin J Am Soc Nephrol. 2011 Oct; 6(10):2395-402.
    View in: PubMed
    Score: 0.008
  93. Metabolic syndrome and kidney disease: a systematic review and meta-analysis. Clin J Am Soc Nephrol. 2011 Oct; 6(10):2364-73.
    View in: PubMed
    Score: 0.008
  94. Low 25-hydroxyvitamin D levels and mortality in non-dialysis-dependent CKD. Am J Kidney Dis. 2011 Oct; 58(4):536-43.
    View in: PubMed
    Score: 0.008
  95. Role of statins in preventing adverse cardiovascular outcomes in patients with chronic kidney disease. Curr Opin Nephrol Hypertens. 2011 Mar; 20(2):146-52.
    View in: PubMed
    Score: 0.007
  96. Phosphate binders for preventing and treating bone disease in chronic kidney disease patients. Cochrane Database Syst Rev. 2011 Feb 16; (2):CD006023.
    View in: PubMed
    Score: 0.007
  97. How to design a randomized controlled trial. Nephrology (Carlton). 2010 Dec; 15(8):732-9.
    View in: PubMed
    Score: 0.007
  98. Development and validation of an electronic health record-based chronic kidney disease registry. Clin J Am Soc Nephrol. 2011 Jan; 6(1):40-9.
    View in: PubMed
    Score: 0.007
  99. Prevalence and correlates of self-reported sexual dysfunction in CKD: a meta-analysis of observational studies. Am J Kidney Dis. 2010 Oct; 56(4):670-85.
    View in: PubMed
    Score: 0.007
  100. Referral patterns of primary care physicians for chronic kidney disease in general population and geriatric patients. Clin Nephrol. 2010 Apr; 73(4):260-7.
    View in: PubMed
    Score: 0.007
  101. Terlipressin in hepatorenal syndrome: a systematic review and meta-analysis. Int Urol Nephrol. 2011 Mar; 43(1):175-84.
    View in: PubMed
    Score: 0.007
  102. Urinary albumin excretion, HMW adiponectin, and insulin sensitivity in type 2 diabetic patients undergoing bariatric surgery. Obes Surg. 2010 Mar; 20(3):308-15.
    View in: PubMed
    Score: 0.007
  103. Statins for prevention of contrast-induced nephropathy in patients undergoing non-emergent percutaneous coronary intervention. Nephrology (Carlton). 2010 Mar; 15(2):165-70.
    View in: PubMed
    Score: 0.007
  104. Metabolic syndrome and mild to moderate chronic kidney disease among minorities. Semin Nephrol. 2010 Jan; 30(1):51-8.
    View in: PubMed
    Score: 0.007
  105. Weight loss interventions in chronic kidney disease: a systematic review and meta-analysis. Clin J Am Soc Nephrol. 2009 Oct; 4(10):1565-74.
    View in: PubMed
    Score: 0.007
  106. Benefits and harms of phosphate binders in CKD: a systematic review of randomized controlled trials. Am J Kidney Dis. 2009 Oct; 54(4):619-37.
    View in: PubMed
    Score: 0.007
  107. HMG CoA reductase inhibitors (statins) for dialysis patients. Cochrane Database Syst Rev. 2009 Jul 08; (3):CD004289.
    View in: PubMed
    Score: 0.007
  108. Aldosterone antagonists for preventing the progression of chronic kidney disease. Cochrane Database Syst Rev. 2009 Jul 08; (3):CD007004.
    View in: PubMed
    Score: 0.007
  109. Weighing the evidence for treatment of chronic kidney disease mineral and bone disorder. Nephrology (Carlton). 2009 Jun; 14(4):363-6.
    View in: PubMed
    Score: 0.006
  110. HMG CoA reductase inhibitors (statins) for dialysis patients. Cochrane Database Syst Rev. 2009 Apr 15; (2):CD004289.
    View in: PubMed
    Score: 0.006
  111. HMG CoA reductase inhibitors (statins) for kidney transplant recipients. Cochrane Database Syst Rev. 2009 Apr 15; (2):CD005019.
    View in: PubMed
    Score: 0.006
  112. HMG CoA reductase inhibitors (statins) for people with chronic kidney disease not requiring dialysis. Cochrane Database Syst Rev. 2009 Apr 15; (2):CD007784.
    View in: PubMed
    Score: 0.006
  113. Aldosterone antagonists for preventing the progression of chronic kidney disease: a systematic review and meta-analysis. Clin J Am Soc Nephrol. 2009 Mar; 4(3):542-51.
    View in: PubMed
    Score: 0.006
  114. Bariatric surgery and progression of chronic kidney disease. Surg Obes Relat Dis. 2009 Nov-Dec; 5(6):662-5.
    View in: PubMed
    Score: 0.006
  115. Anti-neutrophil cytoplasmic antibody associated crescentic IgA nephropathy in hematopoietic stem cell transplantation. Clin Nephrol. 2009 Jan; 71(1):59-62.
    View in: PubMed
    Score: 0.006
  116. Associations of serum uric acid with cardiovascular events and mortality in moderate chronic kidney disease. Nephrol Dial Transplant. 2009 Apr; 24(4):1260-6.
    View in: PubMed
    Score: 0.006
  117. Sodium bicarbonate therapy for prevention of contrast-induced nephropathy: a systematic review and meta-analysis. Am J Kidney Dis. 2009 Apr; 53(4):617-27.
    View in: PubMed
    Score: 0.006
  118. Lack of permanent access in late referrals and its implications: not to be forgotten. Am J Med. 2008 Jun; 121(6):e17; author reply e19.
    View in: PubMed
    Score: 0.006
  119. Hospitalist care and length of stay in patients with hip fracture: a systematic review. Arch Intern Med. 2008 May 12; 168(9):1010-1.
    View in: PubMed
    Score: 0.006
  120. A systematic review of patient and health system characteristics associated with late referral in chronic kidney disease. BMC Nephrol. 2008 Feb 25; 9:3.
    View in: PubMed
    Score: 0.006
  121. Meta-analysis of mycophenolate mofetil in IgA nephropathy. Nephrology (Carlton). 2008 Feb; 13(1):90.
    View in: PubMed
    Score: 0.006
  122. Thromboprophylaxis in cancer patients with central venous catheters. A systematic review and meta-analysis. Thromb Haemost. 2008 Jan; 99(1):38-43.
    View in: PubMed
    Score: 0.006
  123. Treatment options for proliferative lupus nephritis: an update of clinical trial evidence. Drugs. 2008; 68(15):2095-104.
    View in: PubMed
    Score: 0.006
  124. Prevalence and predictors of lack of permanent vascular access in early referrals. Am J Kidney Dis. 2007 Oct; 50(4):687.
    View in: PubMed
    Score: 0.006
  125. Choice of extracorporeal dialysis modality: can it be evidence based? Minerva Urol Nefrol. 2007 Sep; 59(3):261-7.
    View in: PubMed
    Score: 0.006
  126. An overlooked differential diagnosis of acute chest pain. South Med J. 2007 Aug; 100(8):850.
    View in: PubMed
    Score: 0.006
  127. Referral to nephrologists for chronic kidney disease care: is non-diabetic kidney disease ignored? Nephron Clin Pract. 2007; 106(3):c113-8.
    View in: PubMed
    Score: 0.006
  128. Timely referral alone may not be enough for patients with chronic kidney disease. Mayo Clin Proc. 2007 Feb; 82(2):252-3.
    View in: PubMed
    Score: 0.006
  129. Impact of two different models on influenza and pneumococcal vaccination in hospitalized patients. South Med J. 2007 Feb; 100(2):140-4.
    View in: PubMed
    Score: 0.006
  130. A systematic review of barriers in access to renal transplantation among African Americans in the United States. Clin Transplant. 2006 Nov-Dec; 20(6):769-75.
    View in: PubMed
    Score: 0.005
  131. Evidence for optimal hemoglobin targets in chronic kidney disease. J Nephrol. 2006 Sep-Oct; 19(5):640-7.
    View in: PubMed
    Score: 0.005
  132. Concomitant intracranial aneurysm and carotid artery stenosis: A therapeutic dilemma. South Med J. 2006 Jul; 99(7):757-8.
    View in: PubMed
    Score: 0.005
  133. Antihypertensive agents in patients with diabetes: trade-off between renal and cardiovascular protection. Diabetes Educ. 2006 Jul-Aug; 32(4):596-602.
    View in: PubMed
    Score: 0.005
  134. Tacrolimus-associated hypomagnesemia in renal transplant recipients. Transplant Proc. 2006 Jun; 38(5):1320-2.
    View in: PubMed
    Score: 0.005
  135. Statins in patients with chronic kidney disease: evidence from systematic reviews and randomized clinical trials. PLoS Med. 2006 May; 3(5):e123.
    View in: PubMed
    Score: 0.005
  136. Idiopathic hypereosinophilic syndrome: a rare but fatal condition presenting with common symptoms. South Med J. 2006 Feb; 99(2):188-9.
    View in: PubMed
    Score: 0.005
  137. Nodular glomerulosclerosis in a non-diabetic patient: case report and review of literature. J Nephrol. 2005 Sep-Oct; 18(5):613-5.
    View in: PubMed
    Score: 0.005
  138. Recurrent pleural and pericardial effusions due to sarcoidosis. PLoS Med. 2005 Mar; 2(3):e63.
    View in: PubMed
    Score: 0.005
  139. Educational intervention: a tool for decreasing medication errors. Int J Qual Health Care. 2005 Feb; 17(1):83.
    View in: PubMed
    Score: 0.005
  140. HMG CoA reductase inhibitors (statins) for dialysis patients. Cochrane Database Syst Rev. 2004 Oct 18; (4):CD004289.
    View in: PubMed
    Score: 0.005
  141. First interim results from FINE-REAL: a prospective, non-interventional, phase 4 study providing insights into the use and safety of finerenone in a routine clinical setting. J Nephrol. 2024 Nov; 37(8):2223-2232.
    View in: PubMed
    Score: 0.005
  142. Angiotensin-converting-enzyme inhibitors and angiotensin receptor blockers for preventing the progression of diabetic kidney disease. Cochrane Database Syst Rev. 2024 04 29; 4:CD006257.
    View in: PubMed
    Score: 0.005
  143. Prevalence of the Cardiovascular-Kidney-Metabolic Syndrome in the United States. J Am Coll Cardiol. 2024 May 07; 83(18):1824-1826.
    View in: PubMed
    Score: 0.005
  144. 2024 Heart Disease and Stroke Statistics: A Report of US and Global Data From the American Heart Association. Circulation. 2024 02 20; 149(8):e347-e913.
    View in: PubMed
    Score: 0.004
  145. Adherence to Plant-Based Diets and Risk of CKD Progression and All-Cause Mortality: Findings From the Chronic Renal Insufficiency Cohort (CRIC) Study. Am J Kidney Dis. 2024 05; 83(5):624-635.
    View in: PubMed
    Score: 0.004
  146. Utilization Rates of SGLT2 Inhibitors Among Patients With Type 2 Diabetes, Heart Failure, and Atherosclerotic Cardiovascular Disease: Insights From the Department of Veterans Affairs. JACC Heart Fail. 2023 08; 11(8 Pt 1):933-942.
    View in: PubMed
    Score: 0.004
  147. Cardiac Structure and Function and Subsequent Kidney Disease Progression in Adults With CKD: The Chronic Renal Insufficiency Cohort (CRIC) Study. Am J Kidney Dis. 2023 08; 82(2):225-236.
    View in: PubMed
    Score: 0.004
  148. Physiological Age by Artificial Intelligence-Enhanced Electrocardiograms as a Novel Risk Factor of Mortality in Kidney Transplant Candidates. Transplantation. 2023 06 01; 107(6):1365-1372.
    View in: PubMed
    Score: 0.004
  149. Design and rationale of FINE-REAL: A prospective study of finerenone in clinical practice. J Diabetes Complications. 2023 04; 37(4):108411.
    View in: PubMed
    Score: 0.004
  150. Heart Disease and Stroke Statistics-2023 Update: A Report From the American Heart Association. Circulation. 2023 02 21; 147(8):e93-e621.
    View in: PubMed
    Score: 0.004
  151. Heart Failure-Type Symptom Score Trajectories in CKD: Findings From the Chronic Renal Insufficiency Cohort (CRIC) Study. Am J Kidney Dis. 2023 04; 81(4):446-456.
    View in: PubMed
    Score: 0.004
  152. Executive summary of the KDIGO 2022 Clinical Practice Guideline for Diabetes Management in Chronic Kidney Disease: an update based on rapidly emerging new evidence. Kidney Int. 2022 11; 102(5):990-999.
    View in: PubMed
    Score: 0.004
  153. Improving chronic kidney disease detection and treatment in the United States: the chronic kidney disease cascade of care (C3) study protocol. BMC Nephrol. 2022 10 12; 23(1):331.
    View in: PubMed
    Score: 0.004
  154. Recurrent Neural Model to Analyze the Effect of Physical Training and Treatment in Relation to Sports Injuries. Comput Intell Neurosci. 2022; 2022:1359714.
    View in: PubMed
    Score: 0.004
  155. Heart failure-type symptom scores in chronic kidney disease: The importance of body mass index. Int J Obes (Lond). 2022 10; 46(10):1910-1917.
    View in: PubMed
    Score: 0.004
  156. Revisiting diuretic choice in chronic kidney disease. Curr Opin Nephrol Hypertens. 2022 09 01; 31(5):406-413.
    View in: PubMed
    Score: 0.004
  157. A Mistake Not to Be Repeated: What Can We Learn from the Underutilization of Statin Therapy for Efficient Dissemination of Cardioprotective Glucose Lowering Agents? Curr Cardiol Rep. 2022 06; 24(6):689-698.
    View in: PubMed
    Score: 0.004
  158. Correlates of Glucagon-Like Peptide-1 Receptor Agonist Use Among Patients With Atherosclerotic Cardiovascular Disease and Type 2 Diabetes Mellitus (from the Department of Veterans Affairs). Am J Cardiol. 2022 06 01; 172:7-10.
    View in: PubMed
    Score: 0.004
  159. Utilization Rates of SGLT2 Inhibitors and GLP-1 Receptor Agonists and Their Facility-Level Variation Among Patients With Atherosclerotic Cardiovascular Disease and Type 2 Diabetes: Insights From the Department of Veterans Affairs. Diabetes Care. 2022 02 01; 45(2):372-380.
    View in: PubMed
    Score: 0.004
  160. Heart Disease and Stroke Statistics-2022 Update: A Report From the American Heart Association. Circulation. 2022 02 22; 145(8):e153-e639.
    View in: PubMed
    Score: 0.004
  161. Correlates of SGLT-2-inhibitiors use among patients with atherosclerotic cardiovascular disease and type 2 diabetes mellitus: Insights from the department of veterans affairs. Am Heart J. 2022 06; 248:160-162.
    View in: PubMed
    Score: 0.004
  162. The landscape of renal replacement therapy in Veterans Affairs Medical Center intensive care units. Ren Fail. 2021 Dec; 43(1):1146-1154.
    View in: PubMed
    Score: 0.004
  163. Association of antibiotic use and acute kidney injury in patients hospitalized with community-acquired pneumonia. Curr Med Res Opin. 2022 Mar; 38(3):443-450.
    View in: PubMed
    Score: 0.004
  164. Clinical events and patient-reported outcome measures during CKD progression: findings from the Chronic Renal Insufficiency Cohort?Study. Nephrol Dial Transplant. 2021 08 27; 36(9):1685-1693.
    View in: PubMed
    Score: 0.004
  165. Social Determinants of Health and Comorbidities Among Individuals with Atherosclerotic Cardiovascular Disease: The Behavioral Risk Factor Surveillance System Survey. Popul Health Manag. 2022 02; 25(1):39-45.
    View in: PubMed
    Score: 0.004
  166. Risk of Potentially Inappropriate Medications in Adults With CKD: Findings From the Chronic Renal Insufficiency Cohort (CRIC) Study. Am J Kidney Dis. 2021 12; 78(6):837-845.e1.
    View in: PubMed
    Score: 0.004
  167. Chronic kidney disease, atherosclerotic plaque characteristics on carotid magnetic resonance imaging, and cardiovascular outcomes. BMC Nephrol. 2021 02 24; 22(1):69.
    View in: PubMed
    Score: 0.004
  168. Nonesterified Fatty Acids and Kidney Function Decline in Older Adults: Findings From the Cardiovascular Health Study. Am J Kidney Dis. 2021 08; 78(2):259-267.
    View in: PubMed
    Score: 0.004
  169. Heart Disease and Stroke Statistics-2021 Update: A Report From the American Heart Association. Circulation. 2021 02 23; 143(8):e254-e743.
    View in: PubMed
    Score: 0.004
  170. Association of Blood Pressure Variability and Diuretics With Cardiovascular Events in Patients With Chronic Kidney Disease Stages 1-5. Hypertension. 2021 03 03; 77(3):948-959.
    View in: PubMed
    Score: 0.004
  171. Aldosterone antagonists in addition to renin angiotensin system antagonists for preventing the progression of chronic kidney disease. Cochrane Database Syst Rev. 2020 10 27; 10:CD007004.
    View in: PubMed
    Score: 0.004
  172. Novel Risk Factors for Progression of Diabetic and Nondiabetic CKD: Findings From the Chronic Renal Insufficiency Cohort (CRIC) Study. Am J Kidney Dis. 2021 01; 77(1):56-73.e1.
    View in: PubMed
    Score: 0.004
  173. Adherence to Healthy Dietary Patterns and Risk of CKD Progression and All-Cause Mortality: Findings From the CRIC (Chronic Renal Insufficiency Cohort) Study. Am J Kidney Dis. 2021 02; 77(2):235-244.
    View in: PubMed
    Score: 0.004
  174. Executive summary of the 2020 KDIGO Diabetes Management in CKD Guideline: evidence-based advances in monitoring and treatment. Kidney Int. 2020 10; 98(4):839-848.
    View in: PubMed
    Score: 0.004
  175. Hip Fracture Risk among Hemodialysis-Dependent Patients Prescribed Opioids and Gabapentinoids. J Am Soc Nephrol. 2020 06; 31(6):1325-1334.
    View in: PubMed
    Score: 0.003
  176. Association of 24-Hour Ambulatory Blood Pressure Patterns with Cognitive Function and Physical Functioning in CKD. Clin J Am Soc Nephrol. 2020 04 07; 15(4):455-464.
    View in: PubMed
    Score: 0.003
  177. Selective Serotonin Reuptake Inhibitor Use and Hip Fracture Risk Among Patients on Hemodialysis. Am J Kidney Dis. 2020 03; 75(3):351-360.
    View in: PubMed
    Score: 0.003
  178. Development and Validation of a Pragmatic Electronic Phenotype for CKD. Clin J Am Soc Nephrol. 2019 09 06; 14(9):1306-1314.
    View in: PubMed
    Score: 0.003
  179. Adiposity and risk of decline in glomerular filtration rate: meta-analysis of individual participant data in a global consortium. BMJ. 2019 01 10; 364:k5301.
    View in: PubMed
    Score: 0.003
  180. Facility-Level Variations in Kidney Disease Care among Veterans with Diabetes and CKD. Clin J Am Soc Nephrol. 2018 12 07; 13(12):1842-1850.
    View in: PubMed
    Score: 0.003
  181. Trends in the Causes of Death among Kidney Transplant Recipients in the United States (1996-2014). Am J Nephrol. 2018; 48(6):472-481.
    View in: PubMed
    Score: 0.003
  182. Dialysis Modality and Incident Atrial Fibrillation in Older Patients With ESRD. Am J Kidney Dis. 2019 03; 73(3):324-331.
    View in: PubMed
    Score: 0.003
  183. Cardiovascular Events after New-Onset Atrial Fibrillation in Adults with CKD: Results from the Chronic Renal Insufficiency Cohort (CRIC) Study. J Am Soc Nephrol. 2018 12; 29(12):2859-2869.
    View in: PubMed
    Score: 0.003
  184. Intra-Arterial versus Intravenous Contrast and Renal Injury in Chronic Kidney Disease: A Propensity-Matched Analysis. Nephron. 2019; 141(1):31-40.
    View in: PubMed
    Score: 0.003
  185. Proton Pump Inhibitors, Histamine-2 Receptor Antagonists, and Hip Fracture Risk among Patients on Hemodialysis. Clin J Am Soc Nephrol. 2018 10 08; 13(10):1534-1541.
    View in: PubMed
    Score: 0.003
  186. Risk profiles for acute health events after incident atrial fibrillation in patients with end-stage renal disease on hemodialysis. Nephrol Dial Transplant. 2018 09 01; 33(9):1590-1597.
    View in: PubMed
    Score: 0.003
  187. Outcomes of ICDs and CRTs in patients with chronic kidney disease: a meta-analysis of 21,000 patients. J Interv Card Electrophysiol. 2018 Oct; 53(1):123-129.
    View in: PubMed
    Score: 0.003
  188. Evolution of Echocardiographic Measures of Cardiac Disease From CKD to ESRD and Risk of All-Cause Mortality: Findings From the CRIC Study. Am J Kidney Dis. 2018 09; 72(3):390-399.
    View in: PubMed
    Score: 0.003
  189. Predicting timing of clinical outcomes in patients?with chronic kidney disease and severely decreased glomerular filtration rate. Kidney Int. 2018 06; 93(6):1442-1451.
    View in: PubMed
    Score: 0.003
  190. Longitudinal Weight Change During CKD Progression and Its Association With Subsequent Mortality. Am J Kidney Dis. 2018 05; 71(5):657-665.
    View in: PubMed
    Score: 0.003
  191. Impact of Uric Acid Levels on Kidney Disease Progression. Am J Nephrol. 2017; 46(4):315-322.
    View in: PubMed
    Score: 0.003
  192. Facility-level variation in diabetes and blood pressure control in patients with diabetes: Findings from the Veterans Affairs national database. Clin Cardiol. 2017 Nov; 40(11):1055-1060.
    View in: PubMed
    Score: 0.003
  193. Association of QT-Prolonging Medication Use in CKD with Electrocardiographic Manifestations. Clin J Am Soc Nephrol. 2017 09 07; 12(9):1409-1417.
    View in: PubMed
    Score: 0.003
  194. Statin use and hip fractures in U.S. kidney transplant recipients. BMC Nephrol. 2017 May 01; 18(1):145.
    View in: PubMed
    Score: 0.003
  195. Renal Replacement Therapy and Incremental Hemodialysis for Veterans with Advanced Chronic Kidney Disease. Semin Dial. 2017 05; 30(3):251-261.
    View in: PubMed
    Score: 0.003
  196. Bariatric Surgery versus Intensive Medical Therapy for Diabetes - 5-Year Outcomes. N Engl J Med. 2017 02 16; 376(7):641-651.
    View in: PubMed
    Score: 0.003
  197. Cardiovascular impact in patients undergoing maintenance hemodialysis: Clinical management considerations. Int J Cardiol. 2017 Apr 01; 232:12-23.
    View in: PubMed
    Score: 0.003
  198. Inflammation and elevated levels of fibroblast growth factor 23 are independent risk factors for?death in chronic kidney disease. Kidney Int. 2017 03; 91(3):711-719.
    View in: PubMed
    Score: 0.003
  199. A Whole-Grain Diet Reduces Cardiovascular Risk Factors in Overweight and Obese Adults: A Randomized Controlled Trial. J Nutr. 2016 Nov; 146(11):2244-2251.
    View in: PubMed
    Score: 0.003
  200. Association of Fibroblast Growth Factor 23 With Atrial Fibrillation in Chronic Kidney Disease, From the Chronic Renal Insufficiency Cohort Study. JAMA Cardiol. 2016 Aug 01; 1(5):548-56.
    View in: PubMed
    Score: 0.003
  201. Pragmatic Clinical Trials in CKD: Opportunities and Challenges. J Am Soc Nephrol. 2016 Oct; 27(10):2948-2954.
    View in: PubMed
    Score: 0.003
  202. Interventions for lowering plasma homocysteine levels in dialysis patients. Cochrane Database Syst Rev. 2016 May 31; (5):CD004683.
    View in: PubMed
    Score: 0.003
  203. Type 2 diabetes and osteoarthritis: a systematic review and meta-analysis. J Diabetes Complications. 2016 07; 30(5):944-50.
    View in: PubMed
    Score: 0.003
  204. Multinational Assessment of Accuracy of Equations for Predicting Risk of Kidney Failure: A Meta-analysis. JAMA. 2016 Jan 12; 315(2):164-74.
    View in: PubMed
    Score: 0.003
  205. Safety analysis of primary bariatric surgery in patients on chronic dialysis. Surg Endosc. 2016 06; 30(6):2583-91.
    View in: PubMed
    Score: 0.003
  206. GFR Estimation Using ?-Trace Protein and ?2-Microglobulin in?CKD. Am J Kidney Dis. 2016 Jan; 67(1):40-8.
    View in: PubMed
    Score: 0.003
  207. Chronic Renal Insufficiency Cohort Study (CRIC): Overview and Summary of Selected Findings. Clin J Am Soc Nephrol. 2015 Nov 06; 10(11):2073-83.
    View in: PubMed
    Score: 0.002
  208. Interventions for lowering plasma homocysteine levels in kidney transplant recipients. Cochrane Database Syst Rev. 2015 May 04; (5):CD007910.
    View in: PubMed
    Score: 0.002
  209. Development of a chronic kidney disease patient navigator program. BMC Nephrol. 2015 May 03; 16:69.
    View in: PubMed
    Score: 0.002
  210. Urinary creatinine excretion, bioelectrical impedance analysis, and clinical outcomes in patients with CKD: the CRIC study. Clin J Am Soc Nephrol. 2014 Dec 05; 9(12):2095-103.
    View in: PubMed
    Score: 0.002
  211. Diabetic kidney disease: a report from an ADA Consensus Conference. Diabetes Care. 2014 Oct; 37(10):2864-83.
    View in: PubMed
    Score: 0.002
  212. Diabetic kidney disease: a report from an ADA Consensus Conference. Am J Kidney Dis. 2014 Oct; 64(4):510-33.
    View in: PubMed
    Score: 0.002
  213. Should monitoring of fibroblast growth factor-23 levels in dialysis patients be a part of routine clinical practice? Semin Dial. 2014 Nov-Dec; 27(6):565-8.
    View in: PubMed
    Score: 0.002
  214. Targeting parathyroid hormone levels in dialysis patients. Semin Dial. 2014 Nov-Dec; 27(6):562-5.
    View in: PubMed
    Score: 0.002
  215. HMG CoA reductase inhibitors (statins) for people with chronic kidney disease not requiring dialysis. Cochrane Database Syst Rev. 2014 May 31; (5):CD007784.
    View in: PubMed
    Score: 0.002
  216. Aldosterone antagonists for preventing the progression of chronic kidney disease. Cochrane Database Syst Rev. 2014 Apr 29; (4):CD007004.
    View in: PubMed
    Score: 0.002
  217. TV Watching, but Not Physical Activity, Is Associated With Change in Kidney Function in Older Adults. J Phys Act Health. 2015 Apr; 12(4):561-8.
    View in: PubMed
    Score: 0.002
  218. Serum testosterone levels and mortality in men with CKD stages 3-4. Am J Kidney Dis. 2014 Sep; 64(3):367-74.
    View in: PubMed
    Score: 0.002
  219. Chronic kidney disease in an electronic health record problem list: quality of care, ESRD, and mortality. Am J Nephrol. 2014; 39(4):288-96.
    View in: PubMed
    Score: 0.002
  220. Bariatric surgery versus intensive medical therapy for diabetes--3-year outcomes. N Engl J Med. 2014 May 22; 370(21):2002-13.
    View in: PubMed
    Score: 0.002
  221. Darbepoetin for the anaemia of chronic kidney disease. Cochrane Database Syst Rev. 2014 Mar 31; (3):CD009297.
    View in: PubMed
    Score: 0.002
  222. Race modifies the association between adiposity and inflammation in patients with chronic kidney disease: findings from the chronic renal insufficiency cohort study. Obesity (Silver Spring). 2014 May; 22(5):1359-66.
    View in: PubMed
    Score: 0.002
  223. Comparative effectiveness of early versus conventional timing of dialysis initiation in advanced CKD. Am J Kidney Dis. 2014 May; 63(5):806-15.
    View in: PubMed
    Score: 0.002
  224. HMG CoA reductase inhibitors (statins) for kidney transplant recipients. Cochrane Database Syst Rev. 2014 Jan 28; (1):CD005019.
    View in: PubMed
    Score: 0.002
  225. Lifestyle-induced decrease in fat mass improves adiponectin secretion in obese adults. Med Sci Sports Exerc. 2014; 46(5):920-6.
    View in: PubMed
    Score: 0.002
  226. Exercise-induced lowering of chemerin is associated with reduced cardiometabolic risk and glucose-stimulated insulin secretion in older adults. J Nutr Health Aging. 2014; 18(6):608-15.
    View in: PubMed
    Score: 0.002
  227. HMG CoA reductase inhibitors (statins) for dialysis patients. Cochrane Database Syst Rev. 2013 Sep 11; (9):CD004289.
    View in: PubMed
    Score: 0.002
  228. Association of metabolic syndrome with kidney function and histology in living kidney donors. Am J Transplant. 2013 Sep; 13(9):2342-51.
    View in: PubMed
    Score: 0.002
  229. Thyroid hormones for acute kidney injury. Cochrane Database Syst Rev. 2013 Jan 31; (1):CD006740.
    View in: PubMed
    Score: 0.002
  230. Association of race and body mass index with ESRD and mortality in CKD stages 3-4: results from the Kidney Early Evaluation Program (KEEP). Am J Kidney Dis. 2013 Mar; 61(3):404-12.
    View in: PubMed
    Score: 0.002
  231. Comparative effectiveness studies to improve clinical outcomes in end stage renal disease: the DEcIDE patient outcomes in end stage renal disease study. BMC Nephrol. 2012 Dec 06; 13:167.
    View in: PubMed
    Score: 0.002
  232. Effects of bariatric surgery on diabetic nephropathy after 5 years of follow-up. Surg Obes Relat Dis. 2013 Jan-Feb; 9(1):7-14.
    View in: PubMed
    Score: 0.002
  233. Benefits and harms of statin therapy for persons with chronic kidney disease: a systematic review and meta-analysis. Ann Intern Med. 2012 Aug 21; 157(4):263-75.
    View in: PubMed
    Score: 0.002
  234. Impact of navigators on completion of steps in the kidney transplant process: a randomized, controlled trial. Clin J Am Soc Nephrol. 2012 Oct; 7(10):1639-45.
    View in: PubMed
    Score: 0.002
  235. The effect of folic acid based homocysteine lowering on cardiovascular events in people with kidney disease: systematic review and meta-analysis. BMJ. 2012 Jun 13; 344:e3533.
    View in: PubMed
    Score: 0.002
  236. Fibroblast growth factor 23 and Inflammation in CKD. Clin J Am Soc Nephrol. 2012 Jul; 7(7):1155-62.
    View in: PubMed
    Score: 0.002
  237. Sexual dysfunction in women with ESRD requiring hemodialysis. Clin J Am Soc Nephrol. 2012 Jun; 7(6):974-81.
    View in: PubMed
    Score: 0.002
  238. Preemptive renal transplant candidate survival, access to care, and renal function at listing. Nephrol Dial Transplant. 2012 Aug; 27(8):3321-9.
    View in: PubMed
    Score: 0.002
  239. Prevalence and correlates of erectile dysfunction in men on chronic haemodialysis: a multinational cross-sectional study. Nephrol Dial Transplant. 2012 Jun; 27(6):2479-88.
    View in: PubMed
    Score: 0.002
  240. 2009 influenza A infection and acute kidney injury: incidence, risk factors, and complications. Am J Nephrol. 2011; 34(1):1-8.
    View in: PubMed
    Score: 0.002
  241. Angiotensin-converting enzyme inhibitors, angiotensin receptor blockers and combined therapy in patients with micro- and macroalbuminuria and other cardiovascular risk factors: a systematic review of randomized controlled trials. Nephrol Dial Transplant. 2011 Sep; 26(9):2827-47.
    View in: PubMed
    Score: 0.002
  242. Glomerular filtration rate slopes have significantly improved among renal transplants in the United States. Transplantation. 2010 Dec 27; 90(12):1499-505.
    View in: PubMed
    Score: 0.002
  243. Interventions for treating sexual dysfunction in patients with chronic kidney disease. Cochrane Database Syst Rev. 2010 Dec 08; (12):CD007747.
    View in: PubMed
    Score: 0.002
  244. How to conduct a randomized trial. Nephrology (Carlton). 2010 Dec; 15(8):740-6.
    View in: PubMed
    Score: 0.002
  245. Implications of the CKD-EPI GFR estimation equation in clinical practice. Clin J Am Soc Nephrol. 2011 Mar; 6(3):497-504.
    View in: PubMed
    Score: 0.002
  246. Marked variation of the association of ESRD duration before and after wait listing on kidney transplant outcomes. Am J Transplant. 2010 Sep; 10(9):2008-16.
    View in: PubMed
    Score: 0.002
  247. Meta-analysis: erythropoiesis-stimulating agents in patients with chronic kidney disease. Ann Intern Med. 2010 Jul 06; 153(1):23-33.
    View in: PubMed
    Score: 0.002
  248. Treatment options for sexual dysfunction in patients with chronic kidney disease: a systematic review of randomized controlled trials. Clin J Am Soc Nephrol. 2010 Jun; 5(6):985-95.
    View in: PubMed
    Score: 0.002
  249. Meta-analysis of the effect of radiofrequency catheter ablation on left atrial size, volumes and function in patients with atrial fibrillation. Am J Cardiol. 2010 May 01; 105(9):1317-26.
    View in: PubMed
    Score: 0.002
  250. How to read a nephrology systematic review. Nephrology (Carlton). 2010 Mar; 15(2):158-64.
    View in: PubMed
    Score: 0.002
  251. Atrial natriuretic peptide for preventing and treating acute kidney injury. Cochrane Database Syst Rev. 2009 Oct 07; (4):CD006028.
    View in: PubMed
    Score: 0.002
  252. Atrial natriuretic peptide for management of acute kidney injury: a systematic review and meta-analysis. Clin J Am Soc Nephrol. 2009 Feb; 4(2):261-72.
    View in: PubMed
    Score: 0.002
  253. Rituximab treatment of fibrillary glomerulonephritis. Am J Kidney Dis. 2008 Dec; 52(6):1158-62.
    View in: PubMed
    Score: 0.002
  254. Pantoea agglomerans: an unusual inciting agent in peritonitis. Perit Dial Int. 2008 Jul-Aug; 28(4):428-30.
    View in: PubMed
    Score: 0.002
  255. Effects of statins in patients with chronic kidney disease: meta-analysis and meta-regression of randomised controlled trials. BMJ. 2008 Mar 22; 336(7645):645-51.
    View in: PubMed
    Score: 0.001
  256. Metaanalysis on effects of cardiac resynchronization therapy in heart failure patients with narrow QRS complex. Cardiol J. 2008; 15(3):230-6.
    View in: PubMed
    Score: 0.001
  257. Haemoglobin targets: we were wrong, time to move on. Lancet. 2007 Feb 03; 369(9559):346-50.
    View in: PubMed
    Score: 0.001
  258. Elevated B-type natriuretic peptide level: use with caution in patients with multiple co-morbidities and presenting with dyspnea. Indian Heart J. 2007 Jan-Feb; 59(1):64-8.
    View in: PubMed
    Score: 0.001
  259. Haemoglobin and haematocrit targets for the anaemia of chronic kidney disease. Cochrane Database Syst Rev. 2006 Oct 18; (4):CD003967.
    View in: PubMed
    Score: 0.001
  260. Angiotensin converting enzyme inhibitors and angiotensin II receptor antagonists for preventing the progression of diabetic kidney disease. Cochrane Database Syst Rev. 2006 Oct 18; (4):CD006257.
    View in: PubMed
    Score: 0.001
  261. Antimicrobial agents and catheter-related interventions to prevent peritonitis in peritoneal dialysis: Using evidence in the context of clinical practice. Int J Artif Organs. 2006 Jan; 29(1):41-9.
    View in: PubMed
    Score: 0.001
  262. Possible cocaine-induced acute renal failure without rhabdomyolysis. J Nephrol. 2006 Jan-Feb; 19(1):108-10.
    View in: PubMed
    Score: 0.001
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.